Correlation Between Tempest Therapeutics and ArriVent BioPharma,
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Tempest Therapeutics and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and ArriVent BioPharma,.
Diversification Opportunities for Tempest Therapeutics and ArriVent BioPharma,
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Tempest and ArriVent is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and ArriVent BioPharma, go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and ArriVent BioPharma,
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the ArriVent BioPharma,. In addition to that, Tempest Therapeutics is 1.79 times more volatile than ArriVent BioPharma, Common. It trades about -0.05 of its total potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about 0.07 per unit of volatility. If you would invest 1,800 in ArriVent BioPharma, Common on August 27, 2024 and sell it today you would earn a total of 945.00 from holding ArriVent BioPharma, Common or generate 52.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 85.48% |
| Values | Daily Returns |
Tempest Therapeutics vs. ArriVent BioPharma, Common
Performance |
| Timeline |
| Tempest Therapeutics |
| ArriVent BioPharma, |
Tempest Therapeutics and ArriVent BioPharma, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tempest Therapeutics and ArriVent BioPharma,
The main advantage of trading using opposite Tempest Therapeutics and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
| ArriVent BioPharma, vs. Tesla Inc | ArriVent BioPharma, vs. Yuexiu Transport Infrastructure | ArriVent BioPharma, vs. Afya | ArriVent BioPharma, vs. Lindblad Expeditions Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |